Log in

ASX:CXLCalix Stock Price, Forecast & News

A$0.68
-0.01 (-1.44 %)
(As of 05/13/2020)
Add
Compare
Today's Range
A$0.68
Now: A$0.69
A$0.69
50-Day Range
A$0.69
MA: A$0.68
A$0.69
52-Week Range
A$0.52
Now: A$0.69
A$1.02
Volume38,998 shs
Average VolumeN/A
Market Capitalization$100.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Calix Limited, a technology company, engages in minerals processing and carbon capture business in Australia and internationally. The company offers ACTI-Mag, a solution for odor control, bio treater efficiency, biogas production, sludge management, and phosphate removal; and AQUA-Cal+, a water conditioner to address problems associated with intense aquaculture. It also provides PROTECTA-Mag, a solution against sewer asset corrosion; and BOOSTER-Mag, a mineral foliar fertilizer. Calix Limited was founded in 2005 and is headquartered in Sydney, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.72 out of 5 stars


Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone61 2 8199 7400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.46 million
Cash FlowA$0.05 per share
Book ValueA$0.19 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$100.95 million
Next Earnings DateN/A
OptionableNot Optionable

Receive CXL News and Ratings via Email

Sign-up to receive the latest news and ratings for CXL and its competitors with MarketBeat's FREE daily newsletter.

Calix (ASX:CXL) Frequently Asked Questions

How has Calix's stock been impacted by COVID-19 (Coronavirus)?

Calix's stock was trading at A$0.79 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CXL shares have decreased by 12.7% and is now trading at A$0.69. View which stocks have been most impacted by Coronavirus.

Has Calix been receiving favorable news coverage?

News articles about CXL stock have been trending very negative recently, InfoTrie Sentiment reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Calix earned a news impact score of -3.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Calix.

Who are some of Calix's key competitors?

What other stocks do shareholders of Calix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Calix investors own include Nanosonics (NAN) and Ecolab (ECL).

Who are Calix's key executives?

Calix's management team includes the following people:
  • Dr. Philip Hargraves Hodgson, MD, CEO & Director
  • Dr. Mark Sceats B.Sc, Ph.D., Co-Founder, Chief Scientific Officer & Exec. Director
  • Mr. Darren Charles B. Com, CFO & Company Sec.
  • Mr. Bill Karis, Gen. Mang. of Sales
  • Mr. Andrew Okely, Gen. Mang. of Strategy & Commercial

What is Calix's stock symbol?

Calix trades on the ASX under the ticker symbol "CXL."

What is Calix's stock price today?

One share of CXL stock can currently be purchased for approximately A$0.69.

How big of a company is Calix?

Calix has a market capitalization of $100.95 million and generates $5.46 million in revenue each year.

What is Calix's official website?

The official website for Calix is www.calix.com.au.

How can I contact Calix?

The company can be reached via phone at 61 2 8199 7400.

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.